ldtimmerman
-
RT @: NYT Editor Keller: We'll Have To Resort To Layoffs
4:53 PM Dec 4th
from TweetDeck
-
RT @: seattlepi.com seeks a genius ASP, VB6, VB.net, SQL database & XML apps coder.
4:52 PM Dec 4th
from TweetDeck
-
Seattle's Fred Hutch cancer center wins $55m NCI contract to be public cancer info clearinghouse.
8:38 AM Dec 4th
from TweetDeck
-
Wellesley, MA-based NormOxys emerges from stealth with new type of oxygen drugs for cancer, heart failure.
8:36 AM Dec 4th
from TweetDeck
-
ZymoGenetics axes 52 jobs, quits discovering immunology drugs, to save cash.
2:38 PM Dec 3rd
from TweetDeck
-
Quitting smoking is good business, good health, as Free & Clear wins Northwest VC deal of the year.
11:55 AM Dec 3rd
from TweetDeck
-
Cambridge, MA-based Alkermes bets $10m on crosstown startup with potential Enbrel rival.
9:48 AM Dec 3rd
from TweetDeck
-
RT @: Google PR fights back against Murdoch in WSJ
6:29 AM Dec 3rd
from TweetDeck
-
Scripps young tech transfer boss seeks to strike deals with industry, not just push paper.
6:28 AM Dec 3rd
from TweetDeck
-
Cambridge, MA-based Vertex Pharmaceuticals raises $443 million in yet another monster stock sale.
11:10 PM Dec 2nd
from TweetDeck
-
San Diego-based Phenomix finds European partner for diabetes drug, deal worth as much as $163m over time.
9:09 AM Dec 2nd
from TweetDeck
-
Rested and ready, Pathway Medical founder scouts UW, rediscovers "itch" to start a new company.
8:02 AM Dec 2nd
from TweetDeck
-
Taris Biomedical, yet another Bob Langer-related MIT spinoff, passes first trial with bladder drug device.
7:59 AM Dec 2nd
from TweetDeck
-
Cambridge, MA-based Dyax shares rocket as it wins FDA approval of first drug for rare inflammatory disease.
4:21 PM Dec 1st
from TweetDeck
-
San Diego-based Santarus shares boom on FDA approval of over-the-counter heartburn med.
3:34 PM Dec 1st
from TweetDeck
-
Xconomy is growing. Here's the kind of journalist we are looking to hire.
11:42 AM Dec 1st
from TweetDeck
-
David Baltimore and John Maraganore to headline event on innovations in San Diego biotech on Dec. 14.
6:12 AM Dec 1st
from TweetDeck
-
Cambridge, MA-based Forma Therapeutics snags $25.5m venture round, second chunk of cash in a big year.
6:08 AM Dec 1st
from TweetDeck
-
Hyper-analytical "insanity" cripples drug R&D, says Alnylam CEO.
6:48 AM Nov 30th
from web
-
Bothell, WA-based Ekos, enduring tough year for medical devices, predicts it will still break even next year.
6:46 AM Nov 30th
from web
|
- Name Luke Timmerman
- Location Seattle
- Bio National Biotechnology Editor, Xconomy
|
